Citigroup
LMAT icon

Citigroup’s LeMaitre Vascular LMAT Stock Holding History

Citigroup’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
12,397
+5,658
+84% +$539K ﹤0.01% 2917
2025
Q4 		$547K Sell
6,739
-3,387
-33% -$292K ﹤0.01% 3530
2025
Q3 		$886K Sell
10,126
-9,762
-49% -$872K ﹤0.01% 3236
2025
Q2 		$1.65M Sell
19,888
-11,184
-36% -$935K ﹤0.01% 2809
2025
Q1 		$2.61M Buy
31,072
+1,219
+4% +$113K ﹤0.01% 2467
2024
Q4 		$2.75M Buy
29,853
+2,428
+9% +$233K ﹤0.01% 2536
2024
Q3 		$2.55M Buy
27,425
+10,651
+63% +$923K ﹤0.01% 2453
2024
Q2 		$1.38M Buy
16,774
+1,941
+13% +$143K ﹤0.01% 2652
2024
Q1 		$984K Buy
14,833
+1,393
+10% +$86K ﹤0.01% 3038
2023
Q4 		$763K Buy
13,440
+5,171
+63% +$271K ﹤0.01% 3071
2023
Q3 		$450K Sell
8,269
-7,402
-47% -$439K ﹤0.01% 3139
2023
Q2 		$1.05M Buy
15,671
+5,295
+51% +$323K ﹤0.01% 2810
2023
Q1 		$534K Sell
10,376
-2,316
-18% -$112K ﹤0.01% 3090
2022
Q4 		$584K Sell
12,692
-171
-1% -$8.01K ﹤0.01% 3055
2022
Q3 		$652K Buy
12,863
+1,682
+15% +$84.1K ﹤0.01% 3038
2022
Q2 		$509K Sell
11,181
-9,806
-47% -$439K ﹤0.01% 3212
2022
Q1 		$975K Buy
20,987
+1,293
+7% +$57.9K ﹤0.01% 2994
2021
Q4 		$989K Buy
19,694
+8,784
+81% +$454K ﹤0.01% 3273
2021
Q3 		$579K Buy
10,910
+1,395
+15% +$78.6K ﹤0.01% 3512
2021
Q2 		$581K Buy
9,515
+7,582
+392% +$403K ﹤0.01% 3601
2021
Q1 		$94K Sell
1,933
-2,363
-55% -$111K ﹤0.01% 4397
2020
Q4 		$174K Buy
4,296
+1,155
+37% +$41.3K ﹤0.01% 5090
2020
Q3 		$103K Sell
3,141
-10,285
-77% -$309K ﹤0.01% 5086
2020
Q2 		$355K Buy
13,426
+6,523
+94% +$171K ﹤0.01% 4561
2020
Q1 		$172K Sell
6,903
-2,228
-24% -$68.8K ﹤0.01% 4853
2019
Q4 		$328K Sell
9,131
-1,168
-11% -$40.3K ﹤0.01% 4779
2019
Q3 		$352K Sell
10,299
-5,630
-35% -$180K ﹤0.01% 4664
2019
Q2 		$446K Buy
15,929
+6,050
+61% +$168K ﹤0.01% 4534
2019
Q1 		$306K Sell
9,879
-688
-7% -$18.4K ﹤0.01% 4686
2018
Q4 		$250K Buy
10,567
+66
+0.6% +$1.8K ﹤0.01% 4793
2018
Q3 		$407K Buy
10,501
+8,435
+408% +$304K ﹤0.01% 4522
2018
Q2 		$69K Sell
2,066
-1,256
-38% -$44.7K ﹤0.01% 6029
2018
Q1 		$120K Buy
3,322
+160
+5% +$5.54K ﹤0.01% 5436
2017
Q4 		$100K Sell
3,162
-25,745
-89% -$882K ﹤0.01% 5639
2017
Q3 		$1.08M Buy
28,907
+15,777
+120% +$537K ﹤0.01% 3279
2017
Q2 		$410K Buy
13,130
+13,108
+59,582% +$379K ﹤0.01% 4157
2017
Q1 		$0 Sell
22
-13,570
-100% -$319K ﹤0.01% 7265
2016
Q4 		$344K Buy
13,592
+11,983
+745% +$266K ﹤0.01% 4779
2016
Q3 		$32K Sell
1,609
-5,066
-76% -$88.5K ﹤0.01% 5940
2016
Q2 		$95K Sell
6,675
-4,190
-39% -$64.1K ﹤0.01% 5120
2016
Q1 		$168K Buy
10,865
+7,244
+200% +$104K ﹤0.01% 5249
2015
Q4 		$63K Buy
3,621
+3,619
+180,950% +$52.4K ﹤0.01% 5750
2015
Q3 		$0 Sell
2
-152
-99% -$1.95K ﹤0.01% 7553
2015
Q2 		$2K Buy
+154
New +$1.52K ﹤0.01% 7134

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Citigroup's LMAT Position: Q1 2026 in Review

Citigroup increased its LeMaitre Vascular (LMAT) stake by 84% in Q1 2026, buying an estimated $539K and bringing the position to 12,397 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2917.

Citigroup first reported a position in LMAT in Q2 2015 and has held it in 44 quarters since. The position peaked at $2.75M in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Citigroup held 12,397 shares of LeMaitre Vascular worth $1.35M as of Q1 2026.
  • Citigroup bought 5,658 LeMaitre Vascular shares in Q1 2026, an estimated $539K.
  • LeMaitre Vascular made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2917 holding.
  • Citigroup first reported a position in LeMaitre Vascular in Q2 2015 and has held it in 44 quarters since.
  • Citigroup's LeMaitre Vascular position peaked at $2.75M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.